Our results indicate that these hybrid cells possessed hyper-methylated CpG sites in the proximal promoter of ZNF350. Furthermore, we provide evidence that hyper-methylation of the ZNF350 promoter may be one of the crucial determinants for the acquisition of increased migratory capabilities in colon cancer cells. Here, ZNF350 is linked to malignant colon neoplasm.